Logos Global Management LP Tg Therapeutics, Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $35.4 Million - $46.2 Million	-850,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $22.7 Million - $49.4 Million	-900,000 Reduced 51.43%	850,000 $44.2 Million
Q3 2020 Nov 16, 2020	BUY	$18.49 - $27.24 $16.6 Million - $24.5 Million	900,000 Added 105.88%	1,750,000 $46.8 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $5.34 Million - $13.1 Million	600,156 Added 240.21%	850,000 $16.6 Million
Q1 2020 May 15, 2020	BUY	$7.14 - $15.99 $1.78 Million - $4 Million	249,844 New	249,844 $2.46 Million

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.